N. Groom

Protocol for the CONVERT trial—Concurrent ONce-daily VErsus twice-daily RadioTherapy: an international 2-arm randomised controlled trial of concurrent chemoradiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status

Corinne Faivre‐Finn, S. Falk, Linda Ashcroft et al. · BMJ Open · 2016 · 41 citations · Full text

Medicine, Oncology, Radiation Oncology +14

The evaluation of low dose hyper-radiosensitivity in normal human skin

J. Harney, Nihal Shah, Susan Short et al. · Radiotherapy and Oncology · 2004 · 39 citations

Medicine, Dermatology, Radiation Oncology +14

Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study

Kate Haslett, K. Franks, Gerard G. Hanna et al. · BMJ Open · 2016 · 28 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Isotoxic Intensity Modulated Radiation Therapy in Stage III Non-Small Cell Lung Cancer: A Feasibility Study

Kate Haslett, N. Bayman, K. Franks et al. · International Journal of Radiation Oncology*Biology*Physics · 2020 · 22 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Is pre-trial quality assurance necessary? Experiences of the CONVERT Phase III randomized trial for good performance status patients with limited-stage small-cell lung cancer

N. Groom, Elena Wilson, E. Lyn et al. · British Journal of Radiology · 2014 · 18 citations · Full text

Medicine, Oncology, Radiation Oncology +17